Imaging and fluid biomarkers in frontotemporal dementia. (Q38670219)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28621768%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

review article

1 reference

title

Imaging and fluid biomarkers in frontotemporal dementia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28621768%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

main subject

biomarker

0 references

frontotemporal dementia

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28621768%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Jonathan D Rohrer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28621768%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Laura Donker Kaat

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28621768%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

John C van Swieten

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28621768%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

language of work or name

English

0 references

publication date

16 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28621768%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

published in

Nature Reviews Neurology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28621768%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28621768%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28621768%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

406-419

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28621768%20AND%20SRC:MED&resulttype=core&format=json

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

23 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Classification of primary progressive aphasia and its variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Review: an update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Neuropathological background of phenotypical variability in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Genetics of FTLD: overview and what else we can expect from genetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Advances in neuroimaging in frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Neuroimaging in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Neuroimaging in frontotemporal lobar degeneration--predicting molecular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Imaging frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Conceptualizing neuropsychiatric diseases with multimodal data-driven meta-analyses - the case of behavioral variant frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Gray matter atrophy in behavioral variant frontotemporal dementia: a meta-analysis of voxel-based morphometry studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Towards a nosology for frontotemporal lobar degenerations-a meta-analysis involving 267 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Cognition and anatomy in three variants of primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

On the right side? A longitudinal study of left- versus right-lateralized semantic dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Caudate atrophy on MRI is a characteristic feature of FTLD-FUS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

MRI signatures of the frontotemporal lobar degeneration continuum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Profiles of white matter tract pathology in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Longitudinal white matter changes in frontotemporal dementia subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

White matter tract signatures of the progressive aphasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Whole-brain white matter disruption in semantic and nonfluent variants of primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

White matter imaging contributes to the multimodal diagnosis of frontotemporal lobar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Longitudinal diffusion tensor imaging in frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Divergent Longitudinal Propagation of White Matter Degradation in Logopenic and Semantic Variants of Primary Progressive Aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

White matter damage in frontotemporal lobar degeneration spectrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

The power of neuroimaging biomarkers for screening frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Brain magnetic resonance imaging structural changes in a pedigree of asymptomatic progranulin mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Diagnostic utility of ASL-MRI and FDG-PET in the behavioral variant of FTD and AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Pathophysiology of the behavioral variant of frontotemporal lobar degeneration: A study combining MRI and FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Longitudinal changes of cerebral glucose metabolism in semantic dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Early-stage differentiation between presenile Alzheimer's disease and frontotemporal dementia using arterial spin labeling MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Distinct perfusion patterns in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Multimodal FMRI resting-state functional connectivity in granulin mutations: the case of fronto-parietal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Altered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Functional network connectivity in the behavioral variant of frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Divergent social functioning in behavioral variant frontotemporal dementia and Alzheimer disease: reciprocal networks and neuronal evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

GroupICA dual regression analysis of resting state networks in a behavioral variant of frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Resting state functional connectivity differences between behavioral variant frontotemporal dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Abnormal network connectivity in frontotemporal dementia: evidence for prefrontal isolation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Functional network disruption in the degenerative dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Anterior temporal lobe degeneration produces widespread network-driven dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Disrupted brain connectome in semantic variant of primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Looking for Neuroimaging Markers in Frontotemporal Lobar Degeneration Clinical Trials: A Multi-Voxel Pattern Analysis Study in Granulin Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

PET approaches for diagnosis of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Tau imaging: early progress and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Tau imaging with [18 F]THK-5351 in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Based on the Network Degeneration Hypothesis: Separating Individual Patients with Different Neurodegenerative Syndromes in a Preliminary Hybrid PET/MR Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

CSF biomarkers cutoffs: the importance of coincident neuropathological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Cerebrospinal fluid biomarkers for Alzheimer's disease in patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis with the C9ORF72 repeat expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

CSF biomarkers in frontotemporal lobar degeneration with known pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Neurofilament subunits are integral components of synapses and modulate neurotransmission and behavior in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Neurofilament light chain: a biomarker for genetic frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Plasma neurofilament light chain predicts progression in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Innate immune activation in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Novel CSF biomarkers for frontotemporal lobar degenerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Inflammatory molecules in Frontotemporal Dementia: cerebrospinal fluid signature of progranulin mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: Current status and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Vulnerability of microRNA biogenesis in FTD-ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Biomarkers in Sporadic and Familial Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Rates of hemispheric and lobar atrophy in the language variants of frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Regional differences in white matter breakdown between frontotemporal dementia and early-onset Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

MRI signatures of brain macrostructural atrophy and microstructural degradation in frontotemporal lobar degeneration subtypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Phonologic errors as a clinical marker of the logopenic variant of PPA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Multiparametric computer-aided differential diagnosis of Alzheimer's disease and frontotemporal dementia using structural and advanced MRI.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Cerebrospinal fluid biomarkers can play a pivotal role in the diagnostic work up of primary progressive aphasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Definite behavioral variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Cerebrospinal fluid biomarkers in Progranulin mutations carriers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

7 January 2021

inferred from DOI database lookup

Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.75

7 January 2021

inferred from DOI database lookup

Fully-automated volumetric MRI with normative ranges: translation to clinical practice

1 reference

12 December 2020

Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group

1 reference

12 December 2020

Cerebral hypometabolism and grey matter density in MAPT intron 10 +3 mutation carriers

1 reference

12 December 2020

Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia.

1 reference

12 December 2020

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

1 reference

12 December 2020

Salience network resting-state activity: prediction of frontotemporal dementia progression

1 reference

12 December 2020

Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.

1 reference

12 December 2020

Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies

1 reference

12 December 2020

Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEUROL.2017.75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28621768%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

23 March 2020

1086046233

0 references

Fatcat ID

release_grcu4mlgbjehpjqfhopi2fesrq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/grcu4mlgbjehpjqfhopi2fesrq

24 November 2022

mapped directly with Wikidata item

1 reference